Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle: Draft Guidance for Industry, Food and Drug Administration Staff, and Other Interested Parties
Information
Type
Guidance
Regulated products
Biologics, Medical Devices
Published
September 6, 2024
Last updated
September 9, 2024
Description
A draft guidance document by the FDA for industry, staff, and interested parties on incorporating voluntary patient preference information throughout a product's life cycle.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)